RxDoctor Payments DataLook up a doctor →

Ramin Raiszadeh, MD

Orthopaedic Surgery of the Spine · San Diego, CANPI 1518021369

Payments from drug & device makers

$917,111in general payments, 2019–2025

Across 238 payments — averaging $3853.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Elements, Inc.$760K
  • DJO, LLC$106K
  • Elutia, Inc.$35K
  • Aesculap Implant Systems, LLC$4K
  • Boston Scientific$3K
  • Medtronic$2K
  • plus $8K from 25 others
$519,806in research payments, 2019–2025

Across 47 payments — averaging $11,060 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spinal Elements, Inc.$514K
  • Intrinsic Therapeutics$6K

What the payments were for

  • Royalty or licence$748,13795%
  • Consulting fees$23,0923%
  • Travel & lodging$2,4100%
  • Food & beverage$11,2191%
  • Gifts$380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$917,111 in reported general payments places this provider in the 90th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$180,137
Medicare patients
333
Services billed
798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen66$1,467
Gabapentin184$1,217
Tizanidine Hcl177$1,149
Lidocaine12$897
Pregabalin19$622
Cephalexin56$613
Methylprednisolone46$328
Naproxen46$301
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$210
Tramadol Hcl68$180
Ibuprofen15$101
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$46
Meloxicam12$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →